Olivier Dewit
Cliniques Universitaires Saint-Luc(BE)Inserm(FR)Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Institut Pierre Louis d‘Épidémiologie et de Santé Publique(FR)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Immunodeficiency and Autoimmune Disorders, Autoimmune and Inflammatory Disorders
Most-Cited Works
- → Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease(2008)2,619 cited
- → Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial(2012)634 cited
- → Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4(2007)560 cited
- → Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study(2017)439 cited
- → The impact of interface usability on trust in Web retailers(2001)391 cited
- → Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection(2016)